5H

53 House LLP

Long-term holder

Total reported value

Reporting period: 2026-03-31 · Number of holdings: 1

53 HOUSE LLP disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged 000000000

     $0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Ikena Oncology INCStock-Other

Holding changes this quarter

Position changes disclosed by 53 House LLP for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1Ikena Oncology INCUnchanged

FAQ

What is 53 House LLP and what type of investor is it?
53 House LLP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are 53 House LLP's largest equity positions?
Based on the latest 13F filing, 53 House LLP's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did 53 House LLP make in its most recent portfolio filing?
No notable portfolio changes were recorded for 53 House LLP in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does 53 House LLP focus on?
Sector breakdown data is not yet available for 53 House LLP. Check back after the next 13F processing cycle.